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Abstract 
In  the  field  of  neurosurgery,  like  in  other  surgical  specialties,  the  last  decades  have  brought  major 
achievements. The series of revolutionary discoveries has started during the last century in the fifties, with stereotactic 
radiosurgery, then continued with the implementation of operative microscope (during the seventies), the endovascular 
embolisation  in  the  nineties  and  finally  with  the  major  improvement  in  robotic  neurosurgery  and  molecular 
neurosurgery at the beginning of this century. 
The major innovation has been brought not only in the field of therapeutical measures but also in the field of 
neuro-imaging.  Thus,  the  modern  MRI  with  more  than  3  Tesla,  can  reveal  to  the  neurosurgeon  the  most  intimate 
structures of the nervous system. 
Several important areas in neurosurgery like: vascular neurosurgery, functional neurosurgery and brain tumors 
pathology, benefit from the modern technology and from the latest discoveries from genetic and molecular biology. 
In  conclusion,  summarizing  the  discoveries  of  the  last  decade,  we  emphasize  that  the  related  areas  like 
genetics,  molecular  biology,  computer  technology  become  more  and  more  important  in  the  future  progress  of  the 
neurosurgery. 
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In the field of neurosurgery, like in other surgical specialties, the last decades have brought 
major achievements. One of the most important of all was the development, at the beginning of the 
fifties,  of  the  stereotactic  neurosurgery,  by  Professor  Lars  Leksell.  This  technique  enabled 
neurosurgeons to  diagnose and treat by means of focused irradiation the deep and inaccessible 
lesions of the brain, like brain tumors and arterio-venous malformations. 
Another important step was the continuous improvement of the intraoperative microscope. 
Therefore, at the beginning of the seventies, the microscope has been used regularly during the 
delicate surgical approaches of the brain and spinal cord lesions. The new techniques described by 
Professor Yasargil and the new concept of the compartmentation of the subarachnoid space have 
brought a major contribution in the field of vascular neurosurgery. These new techniques, including 
the manufacturing of new types of vascular clips, improve significantly mortality and morbidity in 
aneurysm surgery. 
However, these surgical techniques are now almost overdrawn by new minimally invasive 
methods. During the last decades, an innovative procedure was developed by Gugliemi and his 
collaborators. Using this technique, the neuroradiologist is able to introduce inside the intravascular 
system of the patient a specially manufactured metallic coil and place it under fluoroscopic control 
within the aneurysm. Once placed, using an electric pulse, the coil is detached away from the 
catheter and starts a process of thrombosis in the aneurysm. Over the years this technique was 
continuously  improved  and  the  metallic  coils  became  more  and  more  sophisticated,  this 
endovascular procedure therefore replacing the surgical treatment for the aneurysms located in the 
vertebro-basilar circulatory system.   Journal of Medicine and Life  Vol. 1, No.1, January-March 2008 
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Even if the neurosurgical field has known during the last decades major improvements in all 
types of pathology, there are still numerous areas, where new therapeutical solutions need to be 
found.  Of  these,  we  mention  only  the  most  important  ones:  1.  Functional  neurosurgery,  2. 
“Frameless” stereotactic neurosurgery, 3. Robotics in neurosurgery,  4. Neuroregeneration and 5. 
Molecular and cellular therapies in malignant brain tumors 
The major progress made in computer science led to important improvements in the field of 
functional neurosurgery. Thus, the implantable micro-electrodes at basal ganglia level (Figure 1) 
replaced the old destructive procedures and became a standard in the therapeutical algorithm of 
Parkinson’s disease. 
 
 
 
Figure 1: “Deep brain stimulation” system for bilateral stimulation of the basal ganglia in 
Parkinson’s disease. (Medtronic.Inc) 
 
On the other hand, the “deep brain stimulation” procedure performed at globus palidum 
level,  can  be  used  as  a  therapy  in  other  severe  diseases  like:  generalized  distonia  [14]  and 
spasmodic  torticolis  [12].  Some  of  the  most  surprising  effects  of  these  techniques,  recently 
discovered during experimental stimulation, with potential benefits, are: up and down regulation of 
specific genes inside neurons from globus palidum [2] and enhancement of associative learning [8] . 
The  possibility  of  miniaturizing  computing  devices  and  the  development,  from  the 
theoretical and technical point of view, of neural networks, enabled scientists to build artificial 
sensor organs like artificial retina and artificial cochlea. One of the most recent and fascinating 
achievements was the development of an artificial hippocampus [23]. The principles of building 
such a complex structure are shown in Figure 2. 
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Figure 2: The principles of building and the functions of artificial hippocampus [Theodore Berger et 
al., “World's first brain prosthesis revealed”, New Scientist Print Edition, 12 March 2003 (with 
permission)] 
 
Stereotactic radiosurgery has known a continuous development and nowadays includes a 
broad field of pathology such as: deep brain tumors, malformations, cerebelo-pontine angle tumors, 
brain metastases, trigeminal neuralgia, involuntary movements, etc. During the last years, major 
improvements  in  neuroimaging  and  robotics  made  possible  the  development  of  frameless 
radiosurgery. 
Neurosurgery was the first surgical specialty which took advantage of robotics, because of 
the precision required during the surgical procedure addressed to deep brain lesions [3, 10]. The 
evolution of robotics passed through several stages like: the usage of stereotactic coordinates for 
guiding the cerebral lesions biopsy, the acquisition of images in real time, the manufacturing of 
man-machine interface tools in order to improve precision of movement of the human hand (this 
implies also the tenfold decrease of physiological tremor) and the development of endoscopical 
surgical tools with remote control of movements [3, 13]. 
The neurosurgical robot has several basic components: the arm of the  robot, the sensors 
located in the operation room, a six – axe moving system which controls the robot’s arm, a system Journal of Medicine and Life  Vol. 1, No.1, January-March 2008 
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for locating the objects within the operation theatre in three dimensional coordinates and a computer 
system for data processing [3, 10, 13, 15]. 
The robotic systems are of three types: 
- the assistive type system: the procedure is carefully planned during the preoperative period, the 
robot executes the pre-programmed movement and the surgeon supervises the process; 
- tele-surgery: the surgeon uses a touch detection interface and performs the surgical  procedure 
using a special console (joystick); 
- double control system: the surgeon performs the surgical procedure and the robot improves the 
precision of the surgeon’s movement. 
In  conclusion,  by  using  robots  in  neurosurgery,  we  may  improve  the  precision  of  surgical 
procedures and we may develop minimally invasive surgery and tele-surgery.  
  The Cyberknife technology is based on a combination of robotics and radiosurgery (Figure 
3). This technology does not rely any more on the stereotactic frame and it has made possible the 
application of radiotherapy in the treatment of spinal lesions [21]. The main components of the 
system are two advanced computer tomographs which acquire images in real time  and send this 
information to a powerful computer station. Using these data, the computer locates the position of 
the lesion in space in every moment and sends the proper command to a robotic arm which focuses 
a high energy X-ray beam directly to the lesion. Nowadays, this system is so precise that it can be 
used for the treatment of trigeminal neuralgia [16]. 
 
 
 
 
Figure 3: The Cyberknife system with its main components (Accuray 
TM Inc.) 
 
It is well known that the nervous system can not regenerate itself because of the lack of 
nerve cell divisions. Therefore, many efforts have been made in the direction of neuroregeneration, 
using  neural  stem  cells  and  even  mesenchymale  stem  cells.  The  main  reason  of  failure  is  the 
impossibility to create complex three-dimensional structures capable to function and interact with 
other nervous structures. We can only make such a complex structure by using new technologies 
like tissular engineering and nanotechnology. One of the most promising techniques is the so called 
MAPLE DW (matrix assisted pulsed laser evaporation direct write) (Figure 4). Using this special 
procedure, the cells (neural stem cells) can be seeded one by one onto a bio-degradable matrix. The 
matrix is specially molded in a shape similar to the structure we intend to create and contains the 
neurotrophic factors required for the development and differentiation of the neural stem cells into 
neurons [5]. 
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Figure 4: Schematic drawing of MAPLE DW (matrix assisted pulsed laser evaporation direct 
write)” 
 
A possible solution for spinal cord injuries could be the implant of stem cells because of 
their special properties of proliferation and differentiation [11, 18, and 19]. Numerous attempts have 
been  made  in  this  promising  field  with  encouraging  results:  implants  of  fetal  nervous  tissue 
(Bregman,1987), implants of embryonic stem cells (Brustle, 1999), bone-marrow derived stem cells 
(  Prockop,  1997;  Akiyama,  2002),  Schwann  cells  (Kuhlengel,  1997)  or  the  implant  of  several 
combinations of stem cells with a biodegradable matrix and neurotrophic molecules ( Houweling, 
1998;  Woerly,  2001)  etc.  The  olfactory  mucosa  lines  contain  a  special  class  of  cells  named 
Olfactory  Ensheathing  Cells  (OEC).  These  cells  have  a  great  potential  of  differentiation  into 
neurons and glial cells. Animal studies performed until now (implant with olfactory tissue - Alan 
MacKay-Sim,  implant  with  olfactory  glial  fetal  cells  -  Hongyuan  Huang,  China)  proved  the 
therapeutical potential of these cells in traumatic spinal cord injuries [11, 19, 22]. 
The malignant brain tumor still represents a challenging field in modern neurosurgery. Even 
with  complex  strategic  therapeutic  management  applied  (neurosurgical  procedure,  radiotherapy, 
chemotherapy) the results are poor, with 100 % mortality in glioblastoma and a medium survival of 
9-12 months. 
One of the major discoveries during the last years is the isolation and cultivation of tumor 
stem  cells  from  glioblastoma  samples  [25].  This  type  of  cells  represents  a  better  experimental 
model, comparable to the classic glioblastoma cells lines used before (U 87, U 1242, U 251), and 
retains the genotypic and phenotypic characteristics of the original tumor. Another aspect to be 
mentioned is that these cells represent “a cellular pool” of glioblastoma. They can survive during 
radiotherapy and chemotherapy, then proliferate and determine the re-growth of the tumor. Because 
they  share  the  same  properties  with  neural  stem  cells,  these  cells  are  responsible  also  for  the 
infiltrative nature of the glioblastoma. All these evidences compelled scientists to develop new 
drugs against these cells. 
  Many  experiments  have  been  performed  during  the  last  decade  in  order  to  develop  an 
antitumoral vaccine in glioblastoma. First, some specific proteins are isolated form the glioblastoma 
samples. Then, a special type of white cells is isolated from the blood of the patient – the dendritic Journal of Medicine and Life  Vol. 1, No.1, January-March 2008 
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cells. These cells are pulsed with protein molecules isolated before, then are periodically injected 
subcutaneously in order to obtain an immune response against the protein contained within tumor 
cells [20, 24]. 
Research of the last years evidenced an extremely interesting property of the neural stem 
cells  (obtained  from  fetal  tissue  or,  according  to  the  latest  researches,  even  from  the  matured 
nervous tissue), namely their tropism towards the cerebral malignant tumor cells (Abody and collab. 
2000) [1]. Injected at the level of the cerebral parenchyma, the stem cells have the ability to “trace” 
tumor cells, identifying as such the secondary centers and localizing themselves at the level of the 
said  canters  (Ehtesham  and  collab.,  2003)  [6,7].  Once  this  capacity  of  neural  stem  cells  was 
discovered, a problem was raised concerning their use as a therapeutical technique, by transfecting 
them with genes that have antitumoral potential, the synthesis products of which to be released 
directly at the level of the metastatic insemination centre [4]. One method is represented by the 
neural cell transfection with adenoviral vectors that can synthesize the TRAIL tumoricide cytokine 
(Hao and collab.) [9]. It was proved that this substance induces selective apoptosis in transformed 
cells  in  tumors,  without  impeding  normal  glial  cells.  Other  authors  carried  out  the  stem  cell 
transfection with INF-beta synthesizing gene and it was noticed that these cells synthesize high 
levels of IFN-beta able to destroy malign glioma cells in vitro (Nakamizo and collab, 2005) [6].      
Recent research revealed also the ability of stem cells extracted from bone marrow to “trace” the 
cerebral malignant tumor cells along their route of metastatic insemination, expressing the same 
tropism for the malignant tumor cells as the neural stem cells (Nakamizo si colab.) [17]. Therefore, 
the next step will be to obtain the bone marrow during surgical procedure, followed by isolation of 
mesenchymale stem cells, their transfection with tumoricide genes (IFN-beta, IL-2, etc.) and finally 
the inoculation of transfected stem cells in the vascular system of patients. 
In conclusion, summarizing the discoveries of the last decade, we emphasize that the related 
areas like genetics, molecular biology and computer technology become more and more important 
in the future progress of neurosurgery. 
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